93 7325 (Trandolapril 1 mg)
Pill with imprint 93 7325 is Beige, Capsule-shape and has been identified as Trandolapril 1 mg. It is supplied by Teva Pharmaceuticals USA.
Trandolapril is used in the treatment of heart attack; diabetic kidney disease; left ventricular dysfunction; heart failure; high blood pressure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7325
Trandolapril
- Imprint
- 93 7325
- Strength
- 1 mg
- Color
- Beige
- Size
- 8.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
ferric oxide yellow,
lactose anhydrous,
povidone k30,
corn starch,
sodium stearyl fumarate,
FD&C Blue No. 2,
indigotindisulfonate sodium,
aluminum oxide,
FD&C Red No. 40,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7325 | Teva Pharmaceuticals USA, Inc. |
| 42291-0837 | AvKare, Inc. |
More about trandolapril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
- Other brands
- Mavik
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.